The covid vaccines have been making headlines all year, and it seems that this continues due to various reasons.
Now, it’s been revealed by The Washington Post that Moderna decided to halt the patent fight over the covid vaccine with he federal government.
The same online publication noted that the firm said that it is “grateful” to government scientists who collaborated with the company and wants to “avoid any distraction” in the fight against the Omicron variant.
It’s been also revealed that this decision could have implications for the Biden administration’s global vaccination strategy.
The article also reminds readers that officials are currently looking for leverage to share mRNA vaccine discoveries with developing countries. All this is an effort to ramp up worldwide supply.
“It is also expected to turn down the heat on the Cambridge, Mass., vaccine maker, which projected as much as $18 billion in sales from its vaccine this year, and has received stinging criticism for doing too little to share its breakthroughs with poorer nations,” The Washington Post notes.
It is also worth noting the fact that government scientists worked with Moderna in January 2020 to rapidly develop the spike protein technology key to the company’s messenger RNA vaccine.
Omicron symptoms are revealed
Deseret online publication notes that the Omicron variant of the coronavirus continues to spread throughout the world. People have an idea of what Omicron symptoms look like for infected people.
“The ZOE COVID Study, which has analyzed thousands of COVID-19 cases and reported on symptoms of those cases, has revealed the top symptoms for people who were infected with the coronavirus at the time when the omicron variant likely started to spread,” according to CNBC.
The symptoms really seem to be similar to other coronavirus variants. Check out our previous article in order to learn more details about all this.